Immune cell therapy represents a cutting-edge approach that leverages a patient’s own immune cells to identify and eradicate abnormal cells. Because immune cells can circulate throughout the body—including the lymphatic system, bones, and brain—this therapy is well-suited for a wide range of solid tumors, even those at advanced or metastatic stages.
At our treatment center in Japan, the Shin-Yokohama Kato Clinic, we offer patient-specific immune cell therapy plans under the leadership of Dr. Yoichi Kato—one of Japan’s foremost experts in the field. Each step of the therapeutic journey is supported by our dedicated team of professionals, ensuring a comprehensive and well-coordinated treatment experience.
With over two decades of clinical expertise and more than 2,000 documented immune cell therapy cases, Dr. Kato stands among Japan’s most seasoned practitioners. His approach has been effective for 68% of late-stage patients, with 8% achieving complete remission (CR).
Located at Room 1202, 12/F, Hing Wai Building, 36 Queen's Road Central, Central, provides specialized consultations on immune cell therapy. We will facilitate online consultations with Dr. Kato, guiding patients in planning and streamlining their treatment in Japan.
We dedicate ourselves to employing the world’s most advanced immune cell therapy techniques, backed by a top-tier team with extensive experience. By addressing cancer at its root, we offer individualized, precision treatments that safeguard every patient’s health and foster enduring hope.
An advanced treatment approach that leverages a patient’s own immune cells to seek out and destroy cancer cells.
Through dendritic cell therapy, the body’s immune system can be recalibrated to its “healthy baseline,” enabling it to quickly identify and target cancer cells. This breakthrough paves the way for a safer, more effective, and longer-lasting strategy against cancer. It brings unprecedented hope to countless patients.
Through LAK therapy, patients can rapidly strengthen their immune response, effectively targeting and suppressing cancer cells. Additionally, when combined with other treatments—such as dendritic cell (DC) vaccine therapy—or conventional methods, LAK therapy can yield even more comprehensive, synergistic benefits in the battle against cancer.
NK therapy delivers a robust immune offensive against severe diseases and cancer cells. When combined with other treatments—such as LAK therapy, dendritic cell (DC) vaccines, or conventional strategies—it often demonstrates synergistic benefits, providing patients with a proactive route back to health.
Compared to conventional treatments like chemotherapy and radiotherapy, immunotherapy generally has fewer side effects and allows patients to maintain a higher quality of life.
Overall, immunotherapy side effects tend to be less severe than those seen in chemotherapy or radiotherapy, offering new hope to patients in their battle against serious diseases. By working closely with experienced physicians and maintaining healthy habits and a positive mindset, patients can minimize side effects and improve their odds of overcoming illness.
Compared to conventional treatments (chemotherapy, radiotherapy), immunotherapy costs are typically higher, driven by factors like research and development, drug procurement, specialized lab techniques, and a skilled medical team. However, as the technology matures, some treatments and medications are increasingly covered by insurance or governmental support, gradually reducing their out-of-pocket expense.
Explore advanced immunotherapy in Japan, including NK cell therapy Japan. Learn about immunocellular therapy options and the proven success rate for immunotherapy treatments. Get expert insights.
ASIA IMMUNOTHERAPY is a medical group specializing in cutting-edge cancer immune cell therapy. We work in close collaboration with Dr. Yoichi Kato, Japan’s leading authority in the field, to offer advanced, personalized treatments, including options for late-stage and metastatic patients. Our mission is to harness the power of the body's own defense system to fight cancer at its roots.
As this advanced technology is not yet formally available in Hong Kong under the strict ATP regulations, patients currently travel to Japan for treatment at the Shin-Yokohama Kato Clinic. To support them throughout this critical journey, we offer a seamless, one-stop service encompassing everything from gathering medical reports and arranging online consultations with Dr. Kato, to coordinating travel, accommodation, airport pick-up, and professional in-person translation during the treatment process—ensuring a secure and well-supported experience.
Preliminary Data Summary: Dr. Kato’s extensive clinical experience spans over two decades and includes more than 2,000 documented cases of immunocellular therapy. His approach has shown an impressive 68% effectiveness rate in advanced cancer cases, with 8% achieving Complete Remission (CR). Dr. Kato is also a valued shareholder and partner of Asia Immunotherapy, reinforcing our commitment to the highest standard of care.
Japan has long been a pioneer in medical research, particularly in oncology. Choosing Japan for your treatment offers access to nearly five decades of concentrated research and clinical innovation in immunotherapy in Japan.
Immunocellular therapy is a revolutionary treatment approach that leverages a patient’s own immune cells to combat cancer. This involves collecting the patient's immune cells (such as T cells, NK cells, and Dendritic cells), cultivating and activating them in a specialized lab, and then re-infusing them back into the body.
Natural Killer (NK) cells are the immune system’s first line of defense, capable of spontaneously recognizing and killing cancer cells or virus-infected cells. Our advanced protocols include specialized NK cell therapy Japan utilizes as a powerful component of multi-modal treatment plans.
Through laboratory cultivation, we significantly multiply and activate your body's NK cells before re-administration, boosting your aggressive immune capacity against malignant cells.
Dr. Kato and the Shin-Yokohama Clinic have extensive practical experience in delivering high-quality NK cell therapy alongside other cell-based treatments.
Learn more about the benefits and process of NK Cell Therapy here.
Transparency and clinical efficacy are paramount, especially when discussing the success rate for immunotherapy.
Dive deeper into our clinical reports, success stories, and data interpretation.
We believe the patient journey should be seamless and stress-free. Our comprehensive, one-stop service manages the complexity of international medical travel:
Contact Asia Immunotherapy today to schedule your initial consultation and discover how advanced immune cell therapy can offer a pathway to renewed health and enduring hope.
Contact Details:
Theglioblastoma(GBM)immunemicroenvironmentishighlysuppressiveasittargetsandhindersmultiplecomponentsoftheimmunesystem.Checkpointblockade(CB)isbeingevaluatedforGBMpatients.However,biomarkeranalysessugg
Dendriticcellsarepowerfulantigen-presentingcellsthatareessentialfortheprimingofTcellresponses.InadditiontoprovidingT-cell-receptorligandsandco-stimulatorymoleculesfornaiveTcellactivationandexpansion,d
Naturalkiller(NK)cellisaspecializedimmuneeffectorcelltypethatplaysacriticalroleinimmuneactivationagainstabnormalcells.DifferentfromeventsrequiredforTcellactivation,NKcellactivationisgovernedbytheinter
Lecturer in Radiology, St. Marianna University School of Medicine | Vice President, Yokohama Surgical Association. Specialist: Medical Oncology & Gastroenterology
Read Detail
